BoobyBiome Wins £100k Innovate UK Award after Microbials Accelerator participation.

London, 2 May 2024

BoobyBiome, a leading company in infant health, has secured a £100k Biomedical Catalyst Feasibility award from Innovate UK after participating in the LYVA Labs/BioNow Innovate UK Microbials Accelerator Programme. The extra funding enables the company to conduct further research on bacteria isolated from breast milk.

The Accelerator was aimed at SMEs developing microbiomes, biofilms, bacteriophages, and biotherapeutics. Out of 35 eligible companies, BoobyBiome was one of 24 selected to receive guidance from healthcare experts on scaling their products for manufacturing, designing clinical trials, and accessing NHS patients and clinicians. Only eleven companies, including BoobyBiome, then progressed to the next stage of the accelerator, receiving tailored mentoring on technology development, including state-of-the-art R&D support and the opportunity to apply for the £100k award.

Dr. Lydia Mapstone, CEO of BoobyBiome, commented:

“The Microbials Accelerator has been an invaluable experience, providing support that has touched every aspect of our business - from building networks with clinicians and investors to accessing marketing resources and laboratory equipment. Securing this grant marks a fitting culmination to an outstanding nine months of growth and development.”

Now, BoobyBiome will embark on their eight-month project to assess their bacteria's potential for actively improving the developing infant immune system and gut. This project represents a significant step forward in BoobyBiome's mission to revolutionise infant health.

For more information about BoobyBiome and its mission, visit www.boobybiome.com.

Media Contact

Email: info@boobybiome.com

Phone: +447453310464